Free Trial

Catherine Novack Analyst Performance

Analyst at Jones Trading

Catherine Novack is a stock analyst at Jones Trading in the medical sector, covering 7 publicly traded companies. Over the past year, Catherine Novack has issued 7 stock ratings, including buy and hold recommendations. While full access to Catherine Novack's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Catherine Novack's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
7 Last 0 Years
Buy Recommendations
71.43% 5 Buy Ratings
Companies Covered
7 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy71.4%5 ratings
Hold28.6%2 ratings
Sell0.0%0 ratings

Out of 7 total stock ratings issued by Catherine Novack at Jones Trading, the majority (71.4%) have been Buy recommendations, followed by 28.6% Hold.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
7 companies

Catherine Novack, an analyst at Jones Trading, currently covers 7 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
7 companies
100.0%

Catherine Novack of Jones Trading specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
4 companies
57.1%
MED - DRUGS
2 companies
28.6%
MED PRODUCTS
1 company
14.3%

Catherine Novack's Ratings History at Jones Trading

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Aardvark Therapeutics, Inc. stock logo
AARD
Aardvark Therapeutics
10/1/2025Initiated Coverage$13.29$33.00Buy
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
6/26/2025Initiated Coverage$10.42$30.00Buy
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
6/25/2025Lower Price Target$9.25$29.00Buy
Femasys Inc. stock logo
FEMY
Femasys
5/13/2025Lower Price Target$1.10$6.00Buy
Regulus Therapeutics Inc. stock logo
RGLS
Regulus Therapeutics
4/30/2025Reiterated Rating$7.91$7.00Hold
Rallybio Corporation stock logo
RLYB
Rallybio
4/15/2025Reiterated Rating$0.27Hold
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
3/25/2025Initiated Coverage$27.87$45.00Buy